Publication | Closed Access

Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine.

Hematological MalignancyAcute Lymphoblastic LeukaemiaOncologyActive ImmunotherapyMedicineHematologyImmunologyImmunotherapeuticsPharmacotherapyAdult T-cell Leukemia-lymphomaImmunotherapyPharmacologyNew Protocol